CNS Pharmaceuticals, Inc. (CNSP) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for CNS Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.15x | -0.15x | -0.25x | -0.21x | -1.28x | -3.13x |
| P/B Ratio | 0.51x | 0.37x | -1.08x | 0.40x | 2.80x | 2.12x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 1.98x | 3.43x | 0.26x | 2.55x | 3.50x | 8.13x |
| Quick Ratio | 1.98x | 3.43x | 0.26x | 2.55x | 3.50x | 8.13x |
| Leverage | ||||||
| Debt/Equity | 0.07x | 0.05x | -0.07x | 0.05x | 0.06x | 0.03x |
YoY = year-over-year change. Source: FMP..